The website of BTB Drug Development Research Center has been updated. The company logo has been renewed.

2023-04-18

We have received an investment from Kyogin Shining Future Support FundⅢfor SDGs Investment Limited Partnership(a fund jointly established by the Bank of Kyoto and Kyogin Lease & Capital Co., Ltd., a company under the Bank of Kyoto Group).

2023-04-06

The R&D of next-generation immunotherapeutic drugs for cancer at Kyoto University has been approved as a Practical Research for Innovative Cancer Control for FY2023 by the Japan Agency for Medical Research and Development (AMED). We will continue to engage in R&D projects in collaboration with Kyoto University.

2023-03-28

We participated in the 4th Kyoto University LifeScience Showcase @ San Diego 2023 as an academia-affiliated venture company and received the Best Presentation Award.

2023-03-22

Notice of Change of Representative Director

2023-03-20

The next-generation immunotherapeutic drugs for cancer that we are developing through joint research with Kyoto University were featured in a press release by Kyoto University.

2022-12-12

We have been approved for the FY2022 Industry-Academia-Government Co-Creation Project.

2022-07-20

We are delighted to announce our participation in the upcoming event as a venture corporation coming from academia.

2021-12-22

The 5th recorded video of the web seminar "Proposals from Kyoto University," which was held on December 14th, 2021 (Tuesday), co-sponsored by Kyoto University and Kyodai Collaborative (*), has been released on the official YouTube channel.

2021-12-22